MY163022A - 5-hydroxypyrimidine-4-carboxamide derivative - Google Patents
5-hydroxypyrimidine-4-carboxamide derivativeInfo
- Publication number
- MY163022A MY163022A MYPI2012001770A MYPI2012001770A MY163022A MY 163022 A MY163022 A MY 163022A MY PI2012001770 A MYPI2012001770 A MY PI2012001770A MY PI2012001770 A MYPI2012001770 A MY PI2012001770A MY 163022 A MY163022 A MY 163022A
- Authority
- MY
- Malaysia
- Prior art keywords
- alkyl
- ring
- group
- substitutable
- heterocyclic group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009242884 | 2009-10-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY163022A true MY163022A (en) | 2017-07-31 |
Family
ID=43900350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2012001770A MY163022A (en) | 2009-10-21 | 2010-10-20 | 5-hydroxypyrimidine-4-carboxamide derivative |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US8785462B2 (es) |
| EP (1) | EP2492266B1 (es) |
| JP (1) | JP5718236B2 (es) |
| KR (1) | KR101665749B1 (es) |
| CN (1) | CN102712619B (es) |
| AU (1) | AU2010308942C1 (es) |
| BR (1) | BR112012009452A2 (es) |
| CA (1) | CA2780533C (es) |
| CO (1) | CO6460726A2 (es) |
| CY (1) | CY1116974T1 (es) |
| DK (1) | DK2492266T3 (es) |
| ES (1) | ES2549503T3 (es) |
| HK (1) | HK1174621A1 (es) |
| HR (1) | HRP20151110T1 (es) |
| HU (1) | HUE026128T2 (es) |
| IL (1) | IL219243A (es) |
| MX (1) | MX2012004714A (es) |
| MY (1) | MY163022A (es) |
| NZ (1) | NZ600017A (es) |
| PL (1) | PL2492266T3 (es) |
| PT (1) | PT2492266E (es) |
| RS (1) | RS54323B1 (es) |
| RU (1) | RU2550693C2 (es) |
| SI (1) | SI2492266T1 (es) |
| SM (1) | SMT201500268B (es) |
| TW (2) | TW201124397A (es) |
| WO (2) | WO2011049126A1 (es) |
| ZA (1) | ZA201202899B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011049126A1 (ja) | 2009-10-21 | 2011-04-28 | 第一三共株式会社 | ５－ヒドロキシピリミジン－４－カルボキサミド誘導体 |
| WO2013147214A1 (ja) * | 2012-03-30 | 2013-10-03 | 第一三共株式会社 | ５－ヒドロキシピリミジン－４－カルボキサミド誘導体 |
| IN2014DN08653A (es) * | 2012-03-30 | 2015-05-22 | Daiichi Sankyo Companyltd | |
| ES2767583T3 (es) * | 2012-10-26 | 2020-06-18 | Agc Inc | Método para fabricar un compuesto de difluorolactona |
| WO2016054804A1 (en) * | 2014-10-10 | 2016-04-14 | Merck Sharp & Dohme Corp. | Substituted pyrimidines as inhibitors of hif prolyl hydroxylase |
| KR20180093932A (ko) | 2015-12-16 | 2018-08-22 | 다이이찌 산쿄 가부시키가이샤 | 창상 치료제 |
| EP3441070A4 (en) * | 2016-04-08 | 2019-12-11 | Keio University | MEDICINES FOR PREVENTING OR TREATING LACTATACIDOSIS |
| EP3709986B1 (en) * | 2017-11-14 | 2023-11-01 | Merck Sharp & Dohme LLC | Novel substituted biaryl compounds as indoleamine 2,3-dioxygenase (ido) inhibitors |
| TW201936598A (zh) | 2018-02-19 | 2019-09-16 | 日商第一三共股份有限公司 | 炎症性腸病治療劑 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2298301B2 (en) | 2001-12-06 | 2022-11-16 | Fibrogen, Inc. | Medicaments for treating anemia associated with kidney disease |
| ES2362032T3 (es) | 2003-06-06 | 2011-06-27 | Fibrogen, Inc. | Compuestos de heteroarilo que contienen nitrógeno y su uso en el aumento de eritropoyetina endógena. |
| US7459472B2 (en) | 2003-08-08 | 2008-12-02 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds, compositions, and methods of use |
| CN101849943A (zh) * | 2005-06-06 | 2010-10-06 | 菲布罗根公司 | 使用HIFα稳定剂的改进的贫血治疗 |
| WO2007038571A2 (en) | 2005-09-26 | 2007-04-05 | Smithkline Beecham Corporation | Prolyl hydroxylase antagonists |
| US20090176825A1 (en) | 2006-05-16 | 2009-07-09 | Fitch Duke M | Prolyl hydroxylase inhibitors |
| PE20080209A1 (es) * | 2006-06-23 | 2008-05-15 | Smithkline Beecham Corp | Derivados de glicina como inhibidores de prolil hidroxilasa |
| SI2044005T1 (sl) | 2006-06-26 | 2011-01-31 | Warner Chilcott Co Llc | Inhibitorji prolilhidroksilaze in postopki uporabe |
| CL2008000065A1 (es) * | 2007-01-12 | 2008-09-22 | Smithkline Beecham Corp | Compuestos derivados de glicina n-sustituida, inhibidores de hif prolil hidroxilasas; su proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la anemia. |
| CL2008000066A1 (es) | 2007-01-12 | 2008-08-01 | Smithkline Beecham Corp | Compuestos derivados de (5-hidroxi-3-oxo-2,3-dihidropiridazina-4-carbonil)glicina, inhibidores de hif prolil hidroxilasas; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la anem |
| AU2009225869B2 (en) * | 2008-03-18 | 2014-01-23 | Merck Sharp & Dohme Llc | Substituted 4-hydroxypyrimidine-5-carboxamides |
| CN102066337A (zh) * | 2008-04-22 | 2011-05-18 | 第一三共株式会社 | 5-羟基嘧啶-4-甲酰胺化合物 |
| JP2011105708A (ja) * | 2009-10-21 | 2011-06-02 | Daiichi Sankyo Co Ltd | ５−ヒドロキシピリミジン−４−カルボキサミド化合物を含有する医薬組成物 |
| WO2011049126A1 (ja) | 2009-10-21 | 2011-04-28 | 第一三共株式会社 | ５－ヒドロキシピリミジン－４－カルボキサミド誘導体 |
| TW201141839A (en) | 2010-04-19 | 2011-12-01 | Daiichi Sankyo Co Ltd | Substituted 5-hydroxypyrimidine-4-carboxamide compounds |
-
2010
- 2010-10-20 WO PCT/JP2010/068476 patent/WO2011049126A1/ja active Application Filing
- 2010-10-20 EP EP10824975.6A patent/EP2492266B1/en active Active
- 2010-10-20 NZ NZ600017A patent/NZ600017A/en unknown
- 2010-10-20 AU AU2010308942A patent/AU2010308942C1/en active Active
- 2010-10-20 TW TW099135716A patent/TW201124397A/zh unknown
- 2010-10-20 HU HUE10824975A patent/HUE026128T2/en unknown
- 2010-10-20 MX MX2012004714A patent/MX2012004714A/es active IP Right Grant
- 2010-10-20 CA CA2780533A patent/CA2780533C/en active Active
- 2010-10-20 ES ES10824975.6T patent/ES2549503T3/es active Active
- 2010-10-20 PT PT108249756T patent/PT2492266E/pt unknown
- 2010-10-20 WO PCT/JP2010/068477 patent/WO2011049127A1/ja active Application Filing
- 2010-10-20 PL PL10824975T patent/PL2492266T3/pl unknown
- 2010-10-20 DK DK10824975.6T patent/DK2492266T3/en active
- 2010-10-20 CN CN201080058211.0A patent/CN102712619B/zh active Active
- 2010-10-20 RS RS20150670A patent/RS54323B1/en unknown
- 2010-10-20 RU RU2012120749/04A patent/RU2550693C2/ru active
- 2010-10-20 SI SI201031047T patent/SI2492266T1/sl unknown
- 2010-10-20 JP JP2011537279A patent/JP5718236B2/ja active Active
- 2010-10-20 TW TW99135723A patent/TWI469975B/zh active
- 2010-10-20 KR KR1020127010014A patent/KR101665749B1/ko active IP Right Grant
- 2010-10-20 BR BR112012009452A patent/BR112012009452A2/pt not_active Application Discontinuation
- 2010-10-20 US US13/503,340 patent/US8785462B2/en active Active
- 2010-10-20 MY MYPI2012001770A patent/MY163022A/en unknown
-
2012
- 2012-04-17 IL IL219243A patent/IL219243A/en active IP Right Grant
- 2012-04-19 ZA ZA2012/02899A patent/ZA201202899B/en unknown
- 2012-05-18 CO CO12082335A patent/CO6460726A2/es unknown
-
2013
- 2013-02-04 HK HK13101564.9A patent/HK1174621A1/xx unknown
-
2015
- 2015-10-21 HR HRP20151110TT patent/HRP20151110T1/hr unknown
- 2015-10-28 SM SM201500268T patent/SMT201500268B/it unknown
- 2015-11-24 CY CY20151101058T patent/CY1116974T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY163022A (en) | 5-hydroxypyrimidine-4-carboxamide derivative | |
| ES2653265T3 (es) | Morfinanos sustituidos y el uso de éstos | |
| RS53503B1 (en) | AMORPHIC AND CRYSTAL FORM GENZ 112638 HEMITARTARATE AS A GLYCOSILKERAMIDE SYNTHASIS INHIBITOR | |
| BR112013000868A2 (pt) | derivados de pirazol [1,5a] e tieno [3,2b] pirimidina como modulares de irak4 | |
| WO2011031554A3 (en) | Heterocyclic compounds as janus kinase inhibitors | |
| MY184008A (en) | Aryl pyridine as aldosterone synthase inhibitors | |
| WO2008083248A3 (en) | Cyclopamine analogs | |
| MX2008014908A (es) | Compuesto heterociclico nuevo o sal del mismo e intermedio del mismo. | |
| UA105190C2 (ru) | Цефалоспорины, которые содержат катехольную группу | |
| AR087919A1 (es) | Heterociclos biciclicos como inhibidores de irak4 | |
| CO6231035A2 (es) | Novedoso compuesto heteromonociclico que tiene propiedades superiores como agente farmaceutico | |
| MY150596A (en) | Hsp90 inhibitors | |
| PT2470546E (pt) | Compostos de hexa-hidrooxazinopteridina para serem utilizados como inibidores de mtor | |
| MX2015012629A (es) | Compuestos de imidazo piridina. | |
| MX2009013626A (es) | DERIVADO DE 17ß-CIANO-18A-HOMO-19-NOR-ANDROST-4-ENO, SU USO Y MEDICAMENTO QUE LO CONTIENE. | |
| MX2011008176A (es) | Derivados de 3,3'-espiroindolinona como agentes anticancerigenos. | |
| MY159870A (en) | Piperazine compound capable of inhibiting prostaglandin d synthase | |
| MX2012003982A (es) | Pirrolidinas n-substituidas. | |
| AU2011209274A8 (en) | Substituted naphthyridines and their use as Syk kinase inhibitors | |
| WO2010144499A3 (en) | Urea derivatives as kinase inhibitors | |
| WO2009116067A3 (en) | Novel derivatives of acyl cyanopyrrolidines | |
| WO2008117796A1 (ja) | 新規ムチリン誘導体 | |
| WO2011079230A3 (en) | Heterocyclic compounds as janus kinase inhibitors | |
| MX2022001264A (es) | Compuesto de urea para antagonizar el receptor del acido lisofosfatidico tipo 1. | |
| WO2012103071A3 (en) | Compounds and compositions |